Structural basis of alpha-tocopherol succinate as an antineoplastic agent
Li, H.; Wu, K.
Wei Sheng Yan Jiu 33(4): 512-514
2004
ISSN/ISBN: 1000-8020 PMID: 15461294 Document Number: 579075
Alpha-tocopherol succinate is a redox-silent analog of alpha-tocopherol which is the major component of vitamin E. Recently, the research findings showed that, as a kind of pro-vitamin E, alpha-tocopherol succinate possesses antineoplastic activity which alpha-tocopherol lacks of. In this review paper, the link between the structure and antineoplastic activity of alpha-tocopherol succinate was focused.
Document emailed within 1 workday
Related Documents
Kaempf, D.E.; Miki, M.; Ogihara, T.; Okamoto, R.; Konishi, K.; Mino, M. 1994: Assessment of vitamin e nutritional status in neonates, infants and children--on the basis of alpha-tocopherol levels in blood components and buccal mucosal cells International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 64(3): 185-191Petrova, G.V.; Kapralov, A.A.; Izhokina, I.A.; Donchenko, G.V. 1994: Effect of alpha-tocopherol and ubiquinone on mitochondrial RNA polymerase activity. the role of tocopherol-binding proteins Biokhimiia 59(4): 575-581
Parkhomets', V.P.; Silonov, S.B.; Donchenko, H.V. 2001: Effect of alpha-tocopherol, tocopheryl quinone and other complexes with tocopherol-binding proteins on the activity of enzymes metabolizing arachidonic acid Ukrains'kyi Biokhimichnyi Zhurnal 73(1): 43-47
Jørgensen, P.L. 1988: Overview: structural basis for coupling of E1-E2 transitions in alpha beta-units of renal Na,K-ATPase to Na,K-translocation Progress in Clinical and Biological Research 268a: 19-38
Nomoto, M.; Izumi, H.; Ise, T.; Kato, K.; Takano, H.; Nagatani, G.; Shibao, K.; Ohta, R.; Imamura, T.; Kuwano, M.; Matsuo, K.; Yamada, Y.; Itoh, H.; Kohno, K. 1999: Structural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells Cancer Research 59(24): 6214-6222
González-Pérez, O.; Moy-López, N.Angélica.; Guzmán-Muñiz, J. 2008: Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 60(1): 58-67
Milne, D.B.; Botnen, J. 1986: Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography Clinical Chemistry 32(5): 874-876
Hitt, C. 1994: Paclitaxel: a new antineoplastic agent Connecticut Medicine 58(3): 175-177
Semonský, M.; Zikán, V.; Veselá, H. 1973: Cytembena Spofa--a new antineoplastic agent Ceskoslovenska Farmacie 22(7): 313-321
Klener, P. 1979: Common principles of antineoplastic chemotherapy and their theoretical basis Vnitrni Lekarstvi 25(2): 178-183
Inglot, A.D. 1980: Interferon as an antiviral, antineoplastic and immunomodulating agent Postepy Higieny i Medycyny Doswiadczalnej 34(2): 89-105
Pal, S.; Mukherjea, K.; Bhattacharya, R.; Maity, P. 1997: Pt-ATP as an antineoplastic agent in an experimental mice model system Journal of Experimental and Clinical Cancer Research: Cr 16(3): 255-260
Gol'dberg, E.D.; Borovskaia, T.G.; Timina, E.A.; Fomina, T.I.; Gol'dberg, V.E. 1997: Spermatogenesis in rats after administration of the antineoplastic agent vepesid Biulleten' Eksperimental'noi Biologii i Meditsiny 124(12): 645-648
Moriya, K.; Shimizu, H.; Handa, S.; Sasaki, T.; Sasaki, Y.; Takahashi, H.; Nakamura, S.; Yoshida, H.; Kato, Y. 2017: Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(6): 501-506
Noerr, B. 1990: Vitamin e (alpha-tocopherol) Neonatal Network: Nn 8(4): 85-87
Sampi, K.; Honda, T.; Hayashi, Y.; Hattori, M. 1983: Phase Ii study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(6): 1538-1539
Belousova, A.K. 1972: Molecular basis of the relation between the cytotoxic effect of antineoplastic compounds and the cell cycle phase Voprosy Onkologii 18(8): 88-96
Beal, D.D.; Skibba, J.L.; Croft, W.A.; Cohen, S.M.; Bryan, G.T. 1975: Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats Journal of the National Cancer Institute 54(4): 951-957
Dederer, L.I.; Lankin, V.Z.; Konovalova, A.L.; Gorbacheva, L.B. 1995: Biochemical mechanisms of resistance to a new antineoplastic agent amin(cyclopeptidylamin)-S-(-)-malatoplatinum (II) (cycloplatam) Biokhimiia 60(4): 602-609
Burnusus, Z.I.; Suraĭ, P.F.; Burnusus, K.G. 1991: The determination of alpha-tocopherol in blood serum Laboratornoe Delo 4: 49-51